GLP-1 Receptor Agonists and the Diabetic Foot: Mechanisms, Clinical Evidence, and Practical Considerations

Gabriela E Beraja DO, Jason E. Levine

Open source

DOI
10.1016/j.clindermatol.2026.10.010
Published
2026-10
Container
Clinics in Dermatology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.clindermatol.2026.10.010,
  title = {GLP-1 Receptor Agonists and the Diabetic Foot: Mechanisms, Clinical Evidence, and Practical Considerations},
  author = {Gabriela E Beraja DO and Jason E. Levine},
  year = {2026},
  journal = {Clinics in Dermatology},
  doi = {10.1016/j.clindermatol.2026.10.010},
  url = {https://doi.org/10.1016/j.clindermatol.2026.10.010}
}

RIS

TY  - JOUR
TI  - GLP-1 Receptor Agonists and the Diabetic Foot: Mechanisms, Clinical Evidence, and Practical Considerations
AU  - Gabriela E Beraja DO
AU  - Jason E. Levine
PY  - 2026
JO  - Clinics in Dermatology
DO  - 10.1016/j.clindermatol.2026.10.010
UR  - https://doi.org/10.1016/j.clindermatol.2026.10.010
ER  - 

APA

DO, G. E. B., & Levine, J. E. (2026). GLP-1 Receptor Agonists and the Diabetic Foot: Mechanisms, Clinical Evidence, and Practical Considerations. Clinics in Dermatology. https://doi.org/10.1016/j.clindermatol.2026.10.010

Source records